


FDA: Opioid Labels Must Include Info About Naloxone
The Food and Drug Administration recently announced it would require drug manufacturers to include information about naloxone on the labels of opioid painkillers. Naloxone, often referred to by the brand name Narcan, has been used in the U.S. to reverse opioid...
Proposed Bill Could Make Remote Addiction Treatment Permanent
U.S. Senators Rob Portman (R-OH) and Sheldon Whitehouse (D-RI) recently introduced the Telehealth Response for E-prescribing Addiction Therapy Services (TREATS) Act to support the expansion of telehealth services for substance use disorder treatment. The bill would...
SAMHSA : Health Privacy Rule Revised, Modernizing Care Coordination for Americans Seeking Treatment for Substance Use Disorders
The Substance Abuse and Mental Health Services Administration (SAMHSA) has announced the adoption of the revised Confidentiality of Substance Use Disorder Patient Records regulation, 42 CFR Part 2. The new rule advances the integration of healthcare for individuals...